Medical technology firms in Germany see recent regulatory and political changes in their country as largely positive, with one or two exceptions. Tobias Weiler, head of the medical technology department of industry association Spectaris, tells Ashley Yeo about his hopes and fears for the industry...
Scrip Regulatory Affairs
New Rules on Centralised Authorisation for Device Trials in Germany Continue to Frustrate Industry
29 June 2010
Ashley Yeo
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
